Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T14:51:54.181Z.
Calculation as of: 2026-10-06T14:51:54.181Z.
Quote observation: 2026-10-06T14:49:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: dc19b8de49e3e4106715fdbdfbea2d0d88a0c8d359e91a5f261ed42d8782af4c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2021-04-01.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
EV/SALES RATIO AVG TTM
8.10x
EV/SALES RATIO AVG 3Y
5.48x
EV/SALES RATIO AVG 5Y
6.15x
EV/SALES RATIO AVG 10Y
6.15x
EV/SALES RATIO AVG 15Y
215.59x
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Enveric Biosciences, Inc.
Market Cap
$6.67M
EV/Sales Ratio
N/A
TTM Avg
8.10x
3Y Avg
5.48x
5Y Avg
6.15x
Market Cap
$6.47M
EV/Sales Ratio
5.14x
TTM Avg
4.30x
3Y Avg
4.30x
5Y Avg
4.30x
Market Cap
$6.92M
EV/Sales Ratio
3.34x
TTM Avg
3.30x
3Y Avg
4.62x
5Y Avg
27.01x
Market Cap
$6.93M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.01M
EV/Sales Ratio
22.53x
TTM Avg
19.77x
3Y Avg
15.30x
5Y Avg
133.58x
Market Cap
$7.07M
EV/Sales Ratio
7.23x
TTM Avg
5.17x
3Y Avg
3.61x
5Y Avg
2.57x
Market Cap
$7.22M
EV/Sales Ratio
N/A
TTM Avg
1044.91x
3Y Avg
1288.72x
5Y Avg
2112.32x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | $6.67M | N/A | 8.10x | 5.48x | 6.15x |
| Aclarion, Inc. (ACON)vs › | $6.77M | N/A | 36.65x | 72.84x | 72.84x |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.47M | 5.14x | 4.30x | 4.30x | 4.30x |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.92M | 3.34x | 3.30x | 4.62x | 27.01x |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $6.93M | N/A | N/A | N/A | N/A |
| Mangoceuticals, Inc. (MGRX)vs › | $7.01M | 22.53x | 19.77x | 15.30x | 133.58x |
| Biomerica, Inc. (BMRA)vs › | $6.30M | 1.55x | 1.15x | 9.43x | 16.78x |
| Co-Diagnostics, Inc. (CODX)vs › | $7.07M | 7.23x | 5.17x | 3.61x | 2.57x |
| KALA BIO, Inc. (KALA)vs › | $7.22M | N/A | 1044.91x | 1288.72x | 2112.32x |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.23M | N/A | N/A | N/A | N/A |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2021-04-01 | 7.91x |
| 2021-03-31 | 7.76x |
| 2021-03-30 | 7.51x |
| 2021-03-29 | 7.36x |
| 2021-03-26 | 7.93x |
| 2021-03-25 | 8.23x |
| 2021-03-24 | 8.73x |
| 2021-03-23 | 8.43x |
| 2021-03-22 | 8.88x |
| 2021-03-19 | 9.25x |
| 2021-03-18 | 9.03x |
| 2021-03-17 | 9.45x |
| 2021-03-16 | 9.45x |
| 2021-03-15 | 9.62x |
| 2021-03-12 | 9.32x |
| 2021-03-11 | 8.78x |
| 2021-03-10 | 11.41x |
| 2021-03-09 | 7.41x |
| 2021-03-08 | 6.67x |
| 2021-03-05 | 7.04x |
| 2021-03-04 | 7.41x |
| 2021-03-03 | 8.13x |
| 2021-03-02 | 9.05x |
| 2021-03-01 | 9.10x |
| 2021-02-26 | 8.63x |
| 2021-02-25 | 9.18x |
| 2021-02-24 | 9.62x |
| 2021-02-23 | 9.13x |
| 2021-02-22 | 10.39x |
| 2021-02-19 | 10.99x |
| 2021-02-18 | 11.81x |
| 2021-02-17 | 11.34x |
| 2021-02-16 | 12.06x |
| 2021-02-12 | 11.61x |
| 2021-02-11 | 12.23x |
| 2021-02-10 | 12.30x |
| 2021-02-09 | 10.79x |
| 2021-02-08 | 11.19x |
| 2021-02-05 | 10.74x |
| 2021-02-04 | 10.34x |
| 2021-02-03 | 10.77x |
| 2021-02-02 | 10.64x |
| 2021-02-01 | 9.77x |
| 2021-01-29 | 9.32x |
| 2021-01-28 | 9.60x |
| 2021-01-27 | 9.65x |
| 2021-01-26 | 10.81x |
| 2021-01-25 | 10.12x |
| 2021-01-22 | 9.92x |
| 2021-01-21 | 10.05x |
| 2021-01-20 | 10.19x |
| 2021-01-19 | 10.17x |
| 2021-01-15 | 9.97x |
| 2021-01-14 | 10.49x |
| 2021-01-13 | 10.59x |
| 2021-01-12 | 10.62x |
| 2021-01-11 | 12.23x |
| 2021-01-08 | 11.41x |
| 2021-01-07 | 12.03x |
| 2021-01-06 | 9.92x |
| 2021-01-05 | 9.82x |
| 2021-01-04 | 10.02x |
| 2020-12-31 | 10.72x |
| 2020-12-30 | 14.84x |
| 2020-12-29 | 17.02x |
| 2020-12-28 | 36.89x |
| 2020-12-24 | 16.92x |
| 2020-12-23 | 15.73x |
| 2020-12-22 | 17.82x |
| 2020-12-21 | 18.22x |
| 2020-12-18 | 17.92x |
| 2020-12-17 | 16.73x |
| 2020-12-16 | 16.82x |
| 2020-12-15 | 16.73x |
| 2020-12-14 | 15.93x |
| 2020-12-11 | 15.93x |
| 2020-12-10 | 15.93x |
| 2020-12-09 | 15.68x |
| 2020-12-08 | 16.63x |
| 2020-12-07 | 16.03x |
| 2020-12-04 | 15.73x |
| 2020-12-03 | 16.63x |
| 2020-12-02 | 17.62x |
| 2020-12-01 | 14.44x |
| 2020-11-30 | 15.93x |
| 2020-11-27 | 14.54x |
| 2020-11-25 | 14.14x |
| 2020-11-24 | 13.55x |
| 2020-11-23 | 13.94x |
| 2020-11-20 | 12.65x |
| 2020-11-19 | 12.85x |
| 2020-11-18 | 12.35x |
| 2020-11-17 | 12.65x |
| 2020-11-16 | 11.94x |
| 2020-11-13 | 12.88x |
| 2020-11-12 | 12.88x |
| 2020-11-11 | 12.98x |
| 2020-11-10 | 13.07x |
| 2020-11-09 | 14.01x |
| 2020-11-06 | 12.31x |
| 2020-11-05 | 12.79x |
| 2020-11-04 | 11.23x |
| 2020-11-03 | 11.65x |
| 2020-11-02 | 11.47x |
| 2020-10-30 | 11.18x |
| 2020-10-29 | 12.13x |
| 2020-10-28 | 11.84x |
| 2020-10-27 | 12.31x |
| 2020-10-26 | 12.22x |
| 2020-10-23 | 13.45x |
| 2020-10-22 | 13.45x |
| 2020-10-21 | 13.54x |
| 2020-10-20 | 13.73x |
| 2020-10-19 | 14.11x |
| 2020-10-16 | 14.11x |
| 2020-10-15 | 12.69x |
| 2020-10-14 | 12.41x |
| 2020-10-13 | 12.41x |
| 2020-10-12 | 12.50x |
| 2020-10-09 | 12.88x |
| 2020-10-08 | 12.88x |
| 2020-10-07 | 12.41x |
| 2020-10-06 | 11.37x |
| 2020-10-05 | 11.65x |
| 2020-10-02 | 12.50x |
| 2020-10-01 | 12.60x |
| 2020-09-30 | 13.16x |
| 2020-09-29 | 10.81x |
| 2020-09-28 | 10.62x |
| 2020-09-25 | 10.24x |
| 2020-09-24 | 9.96x |
| 2020-09-23 | 10.52x |
| 2020-09-22 | 10.43x |
| 2020-09-21 | 10.43x |
| 2020-09-18 | 10.90x |
| 2020-09-17 | 11.28x |
| 2020-09-16 | 11.75x |
| 2020-09-15 | 10.90x |
| 2020-09-14 | 10.62x |
| 2020-09-11 | 10.81x |
| 2020-09-10 | 10.90x |
| 2020-09-09 | 10.80x |
| 2020-09-08 | 10.45x |
| 2020-09-04 | 10.72x |
| 2020-09-03 | 11.04x |
| 2020-09-02 | 11.47x |
| 2020-09-01 | 11.18x |
| 2020-08-31 | 12.13x |
| 2020-08-28 | 13.07x |
| 2020-08-27 | 12.69x |
| 2020-08-26 | 13.35x |
| 2020-08-25 | 13.82x |
| 2020-08-24 | 13.54x |
| 2020-08-21 | 14.48x |
| 2020-08-20 | 14.77x |
| 2020-08-19 | 15.33x |
| 2020-08-18 | 15.99x |
| 2020-08-17 | 15.43x |
| 2020-08-14 | 2.35x |
| 2020-08-13 | 2.44x |
| 2020-08-12 | 2.43x |
| 2020-08-11 | 2.47x |
| 2020-08-10 | 2.51x |
| 2020-08-07 | 2.44x |
| 2020-08-06 | 2.44x |
| 2020-08-05 | 2.52x |
| 2020-08-04 | 2.46x |
| 2020-08-03 | 2.47x |
| 2020-07-31 | 2.44x |
| 2020-07-30 | 2.43x |
| 2020-07-29 | 2.48x |
| 2020-07-28 | 2.37x |
| 2020-07-27 | 2.36x |
| 2020-07-24 | 2.39x |
| 2020-07-23 | 2.41x |
| 2020-07-22 | 2.48x |
| 2020-07-21 | 2.54x |
| 2020-07-20 | 2.49x |
| 2020-07-17 | 2.43x |
| 2020-07-16 | 2.42x |
| 2020-07-15 | 2.39x |
| 2020-07-14 | 2.33x |
| 2020-07-13 | 2.31x |
| 2020-07-10 | 2.62x |
| 2020-07-09 | 2.60x |
| 2020-07-08 | 2.63x |
| 2020-07-07 | 2.39x |
| 2020-07-06 | 2.35x |
| 2020-07-02 | 2.09x |
| 2020-07-01 | 2.32x |
| 2020-06-30 | 2.08x |
| 2020-06-29 | 2.08x |
| 2020-06-26 | 2.09x |
| 2020-06-25 | 2.20x |
| 2020-06-24 | 2.21x |
| 2020-06-23 | 2.33x |
| 2020-06-22 | 2.31x |
| 2020-06-19 | 2.31x |
| 2020-06-18 | 2.41x |
| 2020-06-17 | 2.32x |
| 2020-06-16 | 2.32x |
| 2020-06-15 | 2.33x |
| 2020-06-12 | 2.35x |
| 2020-06-11 | 2.22x |
| 2020-06-10 | 2.47x |
| 2020-06-09 | 2.69x |
| 2020-06-08 | 2.37x |
| 2020-06-05 | 2.47x |
| 2020-06-04 | 2.55x |
| 2020-06-03 | 3.00x |
| 2020-06-02 | 3.69x |
| 2020-06-01 | 1.82x |
| 2020-05-29 | 1.79x |
| 2020-05-28 | 1.88x |
| 2020-05-27 | 1.99x |
| 2020-05-26 | 2.00x |
| 2020-05-22 | 1.86x |
| 2020-05-21 | 1.65x |
| 2020-05-20 | 1.52x |
| 2020-05-19 | 1.51x |
| 2020-05-18 | 1.54x |
| 2020-05-15 | 1.02x |
| 2020-05-14 | 0.94x |
| 2020-05-13 | 0.93x |
| 2020-05-12 | 0.98x |
| 2020-05-11 | 1.08x |
| 2020-05-08 | 1.08x |
| 2020-05-07 | 1.00x |
| 2020-05-06 | 1.15x |
| 2020-05-05 | 1.32x |
| 2020-05-04 | 0.94x |
| 2020-05-01 | 0.86x |
| 2020-04-30 | 0.85x |
| 2020-04-29 | 0.88x |
| 2020-04-28 | 0.88x |
| 2020-04-27 | 0.89x |
| 2020-04-24 | 0.89x |
| 2020-04-23 | 0.86x |
| 2020-04-22 | 0.88x |
| 2020-04-21 | 0.90x |
| 2020-04-20 | 1.02x |
| 2020-04-17 | 0.90x |
| 2020-04-16 | 0.84x |
| 2020-04-15 | 0.90x |
| 2020-04-14 | 0.88x |
| 2020-04-13 | 0.87x |
| 2020-04-09 | 0.78x |
| 2020-04-08 | 0.78x |
| 2020-04-07 | 0.75x |
| 2020-04-06 | 0.73x |
| 2020-04-03 | 0.72x |
| 2020-04-02 | 0.72x |
| 2020-04-01 | 0.79x |
| 2020-03-31 | 0.89x |
| 2020-03-30 | 0.92x |
| 2020-03-27 | 0.77x |
| 2020-03-26 | 0.81x |
| 2020-03-25 | 0.77x |
| 2020-03-24 | 0.75x |
| 2020-03-23 | 0.68x |
Showing the most recent 260 of 2,076 data points. The chart above shows the full history.
